DF-1601A

N/A

Report date: 2023/02/18 22:37:09
NME

Base Information

Drug NameDF-1601A
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteogenesis stimulants
TargetsNot applicable
Therapy Area/IndicationsFractures, BoneOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDompe Farmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDompe Farmaceutici Spa
Active IndicationsN/A
Inactive IndicationsFractures, BoneOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A